Cargando…

Drug-induced liver injury: the dawn of biomarkers?

Drug-induced liver injury (DILI) is a potentially fatal adverse event with significant medical and economic impact. Many drugs, especially anti-infective, neurologic or pain-modifying substances, act as hepatotoxins. With cardiovascular toxicity, liver toxicity is one of the two leading causes for d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weiler, Stefan, Merz, Michael, Kullak-Ublick, Gerd A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculty of 1000 Ltd 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371234/ https://www.ncbi.nlm.nih.gov/pubmed/25926985 http://dx.doi.org/10.12703/P7-34

Ejemplares similares

Drug-induced liver injury: recent advances in diagnosis and risk assessment
por: Kullak-Ublick, Gerd A, et al.
Publicado: (2017)

Current Concepts of Mechanisms in Drug-Induced Hepatotoxicity
por: Russmann, Stefan, et al.
Publicado: (2009)

Liver Safety Assessment in Special Populations (Hepatitis B, C, and Oncology Trials)
por: Kullak-Ublick, Gerd A., et al.
Publicado: (2014)

Methodology to Assess Clinical Liver Safety Data
por: Merz, Michael, et al.
Publicado: (2014)

The Role of Mitochondria in Drug-Induced Kidney Injury
por: Gai, Zhibo, et al.
Publicado: (2020)

Plasma Sphingoid Base Profiles of Patients Diagnosed with Intrinsic or Idiosyncratic Drug-induced Liver Injury
por: Gai, Zhibo, et al.
Publicado: (2023)

Molecular Mechanisms of Colistin-Induced Nephrotoxicity
por: Gai, Zhibo, et al.
Publicado: (2019)

Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery
por: Peta, Valentina, et al.
Publicado: (2017)

Organic Cation Transporters in Human Physiology, Pharmacology, and Toxicology
por: Samodelov, Sophia L., et al.
Publicado: (2020)

Renal Reabsorption of Folates: Pharmacological and Toxicological Snapshots
por: Samodelov, Sophia L, et al.
Publicado: (2019)

The Farnesoid X Receptor as a Master Regulator of Hepatotoxicity
por: Rausch, Magdalena, et al.
Publicado: (2022)

Characterization of ligand-induced thermal stability of the human organic cation transporter 2 (OCT2)
por: Maane, Max, et al.
Publicado: (2023)

A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry
por: Björnsson, Einar S., et al.
Publicado: (2022)

Lipid Accumulation and Chronic Kidney Disease
por: Gai, Zhibo, et al.
Publicado: (2019)

Renal Glycosuria as a Novel Early Sign of Colistin-Induced Kidney Damage in Mice
por: Samodelov, Sophia L., et al.
Publicado: (2019)

Validation of a transparent decision model to rate drug interactions
por: Far, Elmira, et al.
Publicado: (2012)

Analysis of Drug-Drug Interactions in Swiss Claims Data Using Tizanidine and Ciprofloxacin as a Prototypical Contraindicated Combination
por: Jödicke, Annika M., et al.
Publicado: (2018)

The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
por: Mwinyi, Jessica, et al.
Publicado: (2012)

Effects of Farnesiferol B on Ischemia-Reperfusion-Induced Renal Damage, Inflammation, and NF-κB Signaling
por: Zhang, Lu, et al.
Publicado: (2019)

The organic solute transporters alpha and beta are induced by hypoxia in human hepatocytes
por: Schaffner, Carlos A, et al.
Publicado: (2015)

Farnesoid X receptor activation protects the kidney from ischemia-reperfusion damage
por: Gai, Zhibo, et al.
Publicado: (2017)

A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical Trial
por: Egbring, Marco, et al.
Publicado: (2016)

The Dawn of Character
Publicado: (1911)

Cytokine and Cancer Biomarkers Detection: The Dawn of Electrochemical Paper-Based Biosensor
por: Loo, Song Wei, et al.
Publicado: (2020)

No major effects of vitamin D(3) (1,25 dihydroxyvitamin D(3)) on absorption and pharmacokinetics of folic acid and fexofenadine in healthy volunteers
por: Kullak-Ublick, Gerd A., et al.
Publicado: (2016)

The Dawn of Australian Psychiatry
por: Leigh, Denis
Publicado: (1970)

Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case–control study
por: Grove, Jane I., et al.
Publicado: (2023)

Antibody-drug conjugates in lung cancer: dawn of a new era?
por: Coleman, Niamh, et al.
Publicado: (2023)

Ferroptosis—A New Dawn in the Treatment of Organ Ischemia–Reperfusion Injury
por: Zhou, Linxiang, et al.
Publicado: (2022)

Subaru studies of the cosmic dawn
por: IYE, Masanori
Publicado: (2011)

Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel disease
por: Attinkara, Ragam, et al.
Publicado: (2012)

HER2/CEP17 Ratios and Clinical Outcome in HER2-Positive Early Breast Cancer Undergoing Trastuzumab-Containing Therapy
por: Stocker, Albina, et al.
Publicado: (2016)

The application of cytokeratin-18 as a biomarker for drug-induced liver injury
por: Korver, Samantha, et al.
Publicado: (2021)

The dawn of the liquid biopsy in the fight against cancer
por: Domínguez-Vigil, Irma G., et al.
Publicado: (2017)

Dawning precision treatment for gastric cancer: The latest biomarkers
por: Sun, Keran, et al.
Publicado: (2021)

Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2)
por: Zhang, Lu, et al.
Publicado: (2021)

The dawn of hedgehog inhibitors: Vismodegib
por: Sandhiya, Selvarajan, et al.
Publicado: (2013)

MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury
por: McGill, Mitchell R., et al.
Publicado: (2015)

Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
por: Teschke, Rolf, et al.
Publicado: (2017)

The dawn of synthetic genomics
por: Galperin, Michael Y
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_tq90h0ccg5sbk02p3510ti4b26